|
TOB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.22620000503937E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.31610000464866E-08 |
| Normal-vs-Stage2 |
4.494500005503E-08 |
| Normal-vs-Stage3 |
5.47139999973467E-08 |
| Normal-vs-Stage4 |
2.92330049056488E-10 |
| Stage1-vs-Stage2 |
5.676400E-01 |
| Stage1-vs-Stage3 |
7.104400E-01 |
| Stage1-vs-Stage4 |
5.824800E-04 |
| Stage2-vs-Stage3 |
8.154400E-01 |
| Stage2-vs-Stage4 |
4.496100E-02 |
| Stage3-vs-Stage4 |
1.853680E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.83689999561688E-08 |
| Normal-vs-AfricanAmerican |
1.05049999810092E-08 |
| Normal-vs-Asian |
9.76549999975873E-07 |
| Caucasian-vs-AfricanAmerican |
1.116240E-01 |
| Caucasian-vs-Asian |
2.548800E-01 |
| AfricanAmerican-vs-Asian |
3.789600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.40510000091032E-08 |
| Normal-vs-Female |
8.20450041238985E-10 |
| Male-vs-Female |
6.155000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.40200004331115E-09 |
| Normal-vs-Extreme_Weight |
2.87179999780562E-08 |
| Normal-vs-Obese |
3.49160000023829E-07 |
| Normal-vs-Extreme_Obese |
1.70054999999447E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.403760E-01 |
| Normal_Weight-vs-Obese |
6.076300E-03 |
| Normal_Weight-vs-Extreme_Obese |
1.077990E-01 |
| Extreme_Weight-vs-Obese |
1.818640E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.117000E-01 |
| Obese-vs-Extreme_Obese |
8.586400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.98053000000087E-05 |
| Normal-vs-Age(41-60Yrs) |
2.32240000008765E-07 |
| Normal-vs-Age(61-80Yrs) |
1.35150000080131E-08 |
| Normal-vs-Age(81-100Yrs) |
3.1903999997418E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.534200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.656380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.591580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.071900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.797640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.448400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.83519999974457E-07 |
| Normal-VS-Type2 PRCC |
5.71250002856516E-09 |
| Normal-VS-KIRP CIMP |
3.06260000004777E-06 |
| Normal-VS-Unclassified PRCC |
9.12469999558851E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.183620E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.825000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.788000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.965000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.568200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.477000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.30270003065414E-09 |
| Normal-vs-N1 |
2.42770004099668E-09 |
| Normal-vs-N2 |
3.755600E-02 |
| N0-vs-N1 |
9.223800E-01 |
| N0-vs-N2 |
3.655400E-01 |
| N1-vs-N2 |
5.979000E-01 |
|
|
